t-cell editing
Avoid Chronic Disease Management Risks
A 40% drop in autoimmune flare rates has been recorded in the 2023 NovaCure pilot when AI-driven T-cell editing was applied. This technology integrates real-time vitals with AI-designed edits, allowing clinicians to reprogram immune cells and stave off diabetic flares with a single swipe. Medical Disclaimer: This article is for